Vendor review
Tianjin Finder Chemical TFC reviews
Tianjin Finder Chemical TFC reviews from 108 independent lab tests (Retatrutide, Tirzepatide and BPC-157): grade A, purity and fill accuracy. Is Tianjin Finder Chemical TFC legit? See what its vials showed.
What the lab tests show
108 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 24, 2026 | Tirzepatide | 60 mg | Fail | View | |
| Sep 17, 2026 | GHK-Cu | 99.9 % | 84.3 mg of 100 mg (-16 %) | Pass | View |
| Aug 21, 2026 | Retatrutide | 99.8 % | 34.8 mg of 30 mg (16 %) | Pass | View |
| Aug 3, 2026 | GHK-Cu | 99.9 % | 51.3 mg of 50 mg (3 %) | Pass | View |
| Jul 23, 2026 | Cagrilintide | 94.3 % | 4.34 mg of 5 mg (-13 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 30 mg | Fail | View | |
| Jul 13, 2026 | Retatrutide | 90.6 % | 31.3 mg of 30 mg (4 %) | Pass | View |
| Jul 13, 2026 | Tirzepatide | 99.9 % | 24.5 mg of 20 mg (23 %) | Pass | View |
| Jul 13, 2026 | BPC-157 | 99.9 % | 7.58 mg of 10 mg (-24 %) | Pass | View |
| Jul 13, 2026 | BPC-157 | 10 mg | Fail | View | |
| Jun 26, 2026 | Retatrutide | 99.7 % | 6.1 mg of 5 mg (22 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.5 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.3 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Jun 8, 2026 | BPC-157 | 99.6 % | 8.2 mg of 10 mg (-18 %) | Pass | View |
| Jun 4, 2026 | Retatrutide | 99.7 % | 21.1 mg of 20 mg (6 %) | Pass | View |
| May 24, 2026 | Retatrutide | 60 mg | View | ||
| May 5, 2026 | Tesamorelin | 99.9 % | 9.35 mg of 10 mg (-7 %) | Pass | View |
| Apr 28, 2026 | Tesamorelin | 99.9 % | 8.14 mg of 10 mg (-19 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 19.98 mg of 20 mg (0 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 4.68 mg of 5 mg (-6 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 19.9 mg of 20 mg (-1 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 24.2 mg of 30 mg (-19 %) | Pass | View |
| Mar 6, 2026 | Tesamorelin | 99.9 % | 6.09 mg of 10 mg (-39 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 119.1 mg of 100 mg (19 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 26.8 mg of 30 mg (-11 %) | Pass | View |
| Mar 2, 2026 | Retatrutide | 99.9 % | 34.9 mg of 30 mg (16 %) | Pass | View |
| Feb 26, 2026 | GHK-Cu | 99.9 % | 98.6 mg of 100 mg (-1 %) | Pass | View |
| Feb 20, 2026 | Retatrutide | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Feb 20, 2026 | Tirzepatide | 99.8 % | 9.6 mg of 10 mg (-4 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99.9 % | 31.8 mg of 30 mg (6 %) | Pass | View |
| Feb 16, 2026 | Retatrutide | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Feb 15, 2026 | Tesamorelin | 99.7 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Feb 11, 2026 | Retatrutide | 99.9 % | 10 mg of 10 mg (0 %) | Pass | View |
| Feb 10, 2026 | Retatrutide | 99.7 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Jan 22, 2026 | Tirzepatide | 99.8 % | 27.5 mg of 30 mg (-8 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.6 % | 5.4 mg of 5 mg (8 %) | Pass | View |
| Dec 30, 2025 | Tirzepatide | 95.59 % | 1.31 mg of 15 mg (-91 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.95 % | 10 mg of 10 mg (0 %) | Pass | View |
| Dec 17, 2025 | Tirzepatide | 99.75 % | 29.6 mg of 30 mg (-1 %) | Pass | View |
| Dec 17, 2025 | Tirzepatide | 99.56 % | 15.8 mg of 15 mg (5 %) | Pass | View |
| Dec 17, 2025 | CJC-1295 | 10 mg | Fail | View | |
| Dec 17, 2025 | CJC-1295 | 98.25 % | 10.8 mg of 5 mg (116 %) | Pass | View |
| Dec 11, 2025 | Retatrutide | 99.93 % | 19.9 mg of 20 mg (-1 %) | Pass | View |
| Dec 11, 2025 | Retatrutide | 99.88 % | 30.4 mg of 30 mg (1 %) | Pass | View |
| Dec 4, 2025 | Retatrutide | 99.95 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Dec 2, 2025 | BPC-157 | 98.6 % | 13.8 mg of 10 mg (38 %) | Pass | View |
| Nov 25, 2025 | Retatrutide | 99.95 % | 41.5 mg of 20 mg (108 %) | Pass | View |
| Nov 25, 2025 | Retatrutide | 99.95 % | 21.2 mg of 20 mg (6 %) | Pass | View |
| Nov 17, 2025 | Retatrutide | 99.95 % | 9.36 mg of 10 mg (-6 %) | Pass | View |
| Nov 17, 2025 | CJC-1295 | 97.64 % | 5.02 mg of 5 mg (0 %) | Pass | View |
| Nov 17, 2025 | Cagrilintide | 98.47 % | 4.74 mg of 5 mg (-5 %) | Pass | View |
| Nov 6, 2025 | Tirzepatide | 99.95 % | 32.6 mg of 30 mg (9 %) | Pass | View |
| Nov 4, 2025 | Tirzepatide | 99.91 % | 33.9 mg of 30 mg (13 %) | Pass | View |
| Oct 29, 2025 | Tirzepatide | 99.95 % | 14.6 mg of 30 mg (-51 %) | Pass | View |
| Oct 29, 2025 | Tirzepatide | 99.95 % | 14 mg of 30 mg (-53 %) | Pass | View |
| Oct 24, 2025 | Tirzepatide | 99.8 % | 17.42 mg of 30 mg (-42 %) | Pass | View |
| Oct 23, 2025 | Tirzepatide | 99.95 % | 25.7 mg of 20 mg (29 %) | Pass | View |
| Oct 21, 2025 | Tirzepatide | 99.8 % | 18 mg of 30 mg (-40 %) | Pass | View |
| Oct 13, 2025 | Retatrutide | 99.8 % | 36.6 mg of 30 mg (22 %) | Pass | View |
| Oct 13, 2025 | Retatrutide | 99.7 % | 12.4 mg of 10 mg (24 %) | Pass | View |
What Tianjin Finder Chemical TFC sells
No current listings on record.
About Tianjin Finder Chemical TFC
WhatsApp：+44 07310391222 alicepeptides@gmail.com